1.
Flores JJ, Aguilera EP. New Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD/MASH): Clinical Outcomes and Implementation Challenges. Rev Hosp Ital B.Aires [Internet]. 2026 Sep. 28 [cited 2026 Sep. 29];46(3):e0001314. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/1314